Press monitoring
The new face of TB: drug resistance and HIV
3.7.2007 | Press monitoring
Tuberculosis (TB) is back with a vengeance and it has a new face: the combination of the HIV epidemic with new strains of the disease that are resistant to the existing drugs has seen new TB cases and TB-related deaths skyrocket in the last decade.
Translating form into function
2.7.2007 | Press monitoring
In the last 40 years, scientists have perfected ways to determine the knot-like structure of enzymes, but they’ve been stumped trying to translate the structure into an understanding of function – what the enzyme actually does in the body. This puzzle has hindered drug discovery, since many of the most successful drugs work by blocking enzyme...
New, invisible nano-fibers conduct electricity, repel dirt
1.7.2007 | Press monitoring
Tiny plastic fibers could be the key to some diverse technologies in the future -- including self-cleaning surfaces, transparent electronics, and biomedical tools that manipulate strands of DNA.
Team's Model Aids Understanding Of Protein Networks
30.6.2007 | Press monitoring
An international team of researchers, including several from MIT, has developed a computational model that helps identify relationships between proteins and the enzymes that regulate them.
No More Choking And Burning Eyes? New Approach To Eliminating Allergies, Asthma
29.6.2007 | Press monitoring
Allergies, like the common cold and asthma, have basically defied the best efforts of modern medicine to cure them. Now, a doctoral candidate at the Hebrew University of Jerusalem School of Pharmacy has come up with a new approach that offers hope for getting rid of them.
Scientists reverse symptoms of autism in mice
28.6.2007 | Press monitoring
Scientists may have uncovered a way to reverse symptoms of mental retardation and autism in mice.
Nanotechnology: consumers must be convinced benefits outweigh risks
27.6.2007 | Press monitoring
“There is no doubt that nanotechnology has the potential to make the world a better place,” said Project on Emerging Nanotechnologies Chief Scientist Andrew Maynard. “But if consumers and other stakeholders are not convinced that the benefits outweigh the risks, many applications will not see the light of day. Likewise, if the benefits are unclear...
Researchers Achieve First Signal On Cryogenic Mass Spectrometer
26.6.2007 | Press monitoring
Researchers at Boston University School of Medicine (BUSM) recently achieved first signal on the Cryogenic Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Mass Spectrometry (MALDI-FTMS) being developed at the school's Cardiovascular Proteomics Center (CPC). The Fourier transform mass spectrometer is the highest performance...
Researchers Find New Pathway to Thwart Antibiotic Resistance
25.6.2007 | Press monitoring
Researchers at UAB (University of Alabama at Birmingham) have new information on the structure of a key enzyme in bacteria that could lead to improved antibiotics and less antibiotic resistance. In findings published today online in two complementary papers in Nature, the research team describe the differences in an enzyme called RNA polymerase in...
Protein mutations link to autism
24.6.2007 | Press monitoring
They have shown one protein increases the excitability of nerve cells, while the other inhibits cell activity.
